Business Context and Reporting Period
This Form 8-K filing by Pyrophyte Acquisition Corp. II (PAII) reports events occurring between July 18, 2025, and July 24, 2025. The Company, a Cayman Islands emerging growth company, consummated its initial public offering (IPO) and subsequently partially exercised the underwriters' over-allotment option.
Key Financial Metrics
- Initial IPO Proceeds: $175,000,000 from the sale of 17,500,000 Units at $10.00 per Unit.
- Private Placement Proceeds: $5,050,000 from the sale of 5,050,000 warrants to the Sponsor at $1.00 per warrant.
- Over-Allotment Proceeds: $25,411,500 from the sale of 2,541,150 additional Units at $10.00 per Unit.
- Total Trust Account Balance: $200,411,500 as of July 24, 2025, held in a U.S.-based trust account.
- Deferred Underwriting Commission: $7,875,000 from the IPO plus $1,524,690 from the over-allotment, totaling $9,399,690.
- Founder Shares: Sponsor holds 7,135,721 Class B ordinary shares following a forfeiture of 30,231 shares.
Material Changes
The primary material change is the increase in capital raised and the Trust Account balance due to the partial exercise of the over-allotment option on July 24, 2025. This action increased the total number of Units sold from 17,500,000 to 20,041,150. Consequently, the Sponsor's ownership of founder shares was adjusted downward by 30,231 shares to maintain the intended economic structure.
Outlook, Risks, and Unusual Items
The filing confirms the successful closing of the IPO and the over-allotment, with proceeds secured in a Trust Account managed by Continental Stock Transfer & Trust Company. No specific forward-looking guidance or risk factors beyond standard SPAC disclosures are detailed in this specific 8-K text. The Company is classified as an emerging growth company.
Investor Verification Checklist
- Verify the final Trust Account balance of $200,411,500 against the attached Pro Forma Balance Sheet (Exhibit 99.1).
- Confirm the exact number of outstanding Units (20,041,150) and the corresponding warrant exercise price of $11.50.
- Review the Sponsor's remaining founder share count (7,135,721) to understand voting control dynamics.
- Check the status of the remaining over-allotment option (2,625,000 total option minus 2,541,150 exercised = 83,850 remaining) and its expiration timeline.